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Abstract: 
Aim: The main aim of this study is to find out the drug related problems (DRP) associated with the medications used 
in the management of Asthma.  
Methodology: This prospective observational study was carried out in inpatient department of pulmonology in a 
tertiary care hospital. Patient history/medication interview was done. Other criteria to assess the appropriateness of 
drug related problems was based on BNF, GINA guidelines and modified Beer’s criteria. 
Results: Among the study population of 84 individuals, 36% suffered from other comorbid conditions with asthma, 
and 48% were affected only with asthma. Total numbers of DRPs were 104, in that polypharmacy - 25%, 
contraindications - 16%, drug interactions - 22%, overdose - 15%, underdose - 3% and ADR were found to be 19%.  
Conclusion: This study shows that DRP occur frequently in patients using several drugs to treat chronic diseases. 
The number of DRP was also significantly associated with the number of drugs prescribed. Moreover, patients with 
polypharmacy had significantly more drug related problems. 
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INTRODUCTION: 
Asthma is well-defined as a chronic inflammatory 
disorder of the airways, characterized by recurring 
episodes of wheezing, dyspnoea, chest tightness and 
cough that is frequently revocable, either 
spontaneously or with treatment [1]. Different terms 
such as allergic or asthmatic bronchitis, wheezy 
bronchitis, intrinsic and extrinsic asthma are 
frequently employed in clinical practice [2].  
A drug-therapy related problem (DRP) can be 
defined as an event or circumstance 
involving drug treatment that actually or potentially 
interferes with the patient experiencing an optimum 
outcome of medical care [3,4]. Drug-related 
problems are common in the elderly and include drug 
ineffectiveness, adverse drug effects, over dosage, 
under dosage, and drug interactions [5]. 
Drugs may be ineffective in the elderly because 
clinicians underprescribe (eg, because of increased 
concern about adverse effects) or because adherence 
is poor (eg, because of financial or cognitive 
limitations) [6-9]. 
The main aim of this study is find out the drug related 
problems (DRP) associated with the medications 
used in the management of Asthma. The secondary 
objectives are resolving medication problems by 
pharmacist intervention and providing patient 
counseling for better medication adherence. 
 
MATERIALS AND METHODS: 
This prospective observational study was carried out 
in inpatient department of pulmonology in a tertiary  
 
care hospital. Patients with the age of >18 years, 
diagnosed with asthma and who provided informed 
consent for this study were included. Pregnant and 
psychiatric patients, patients with respiratory co-
morbid conditions like Chronic Obstructive 
Pulmonary Disease were excluded from the study. 
Based on the inclusion and exclusion criteria, 84 
patients were selected for the study. 
 
Data Collection 
A specially designed proforma was used for data 
collection. Inpatient case sheets were documented in 
the case documentation form. Patient 
history/medication interview was done. Other 
criterion to assess the appropriateness of drug therapy 
was based on BNF, GINA guidelines and modified 
Beer’s criteria. 
 
Data Analysis 
Descriptive statistical analysis was performed using 
(SPSS) version 19. Categoric variables were 
described by frequencies and percentages, and 
continuous variables were described by means and 
standard deviations. 
 
RESULTS: 
Drug data and patient characteristic data were 
computed using MS excel. Among the study 
population of 84, majority of patients diagnosed with 
asthma were in the age group of 36-45 (Table 1).  
 
Table 1: Age distribution of patients 
 
Table 2: Drug related problems 
 
 
Age No of patients Percentage 
25-35 16 19% 
36-45 25 30% 
46-55 24 28% 
56-65 19 23% 
Drug related problems Total 
Polypharmacy 26 
Contra indications 17 
Drug interactions 20 
Over dose 14 
Under dose 3 
ADR 20 
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Table 3: Gender distribution of patients with polypharmacy and without polypharmacy. 
 
Gender With polypharmacy Without polypharmacy p value 
Male 11 3 
0.0277* 
Female 15 21 
*p < 0.05 is statistically significant. 
 
Table 4: Comparison of DRPs using ANOVA 
 
Model R R square Adjusted r square Std. Error of the estimate 
1 0.833a 0.693 0.687 0.959 
2 0.902b 0.813 0.805 0.757 
3 0.920c 0.846 0.836 0.695 
4 0.938d 0.879 0.869 0.621 
5 0.943e 0.890 0.877 0.601 
 
A. Predictors: (constant), drug ineractions 
B. Predictors: (constant), drug ineractions, age 
C. Predictors: (constant), drug ineractions, age, overdose 
D. Predictors: (constant), drug ineractions, age, overdose, polypharmacy 
E. Predictors: (constant), drug ineractions, age, overdose, polypharmacy, contraindication 
 
In the study population, 51% were male and 49% 
were female. Among the study population of 84 
individuals, 36% suffered from other comorbid 
conditions with asthma, and 48% were affected only 
with asthma. 
 
There were 104 DRPs observed in the study 
population. Among them, 25% were polypharmacy, 
16% were contraindications, 22% were drug 
interactions, overdose observed was 15%, underdose 
3% and ADR was found to be 19% (Table 2). DRPs 
were found mostly in the elderly people compared to 
adults. 
 
Polypharmacy was found in 26 prescriptions. When 
we compare polypharmacy prescription with normal 
prescription, there was a statistically significant 
difference found among male and female and the 
prescription with and   without polypharmacy (Table 
3).     
Statistical analysis was done using ANOVA. Drug 
interactions, age, overdose, polypharmacy, 
contraindication were all compared and none of them 
showed a statistically significant difference (Table 4).  
 
DISCUSSION: 
Elderly people were found to have more incidences 
of DRPs than adults which is similar to the study 
conducted by Nazerth et al [10]. Among the study 
population of 84 individuals, 36% suffered from 
other comorbid conditions with asthma, and 48% 
were affected only with asthma. Several studies 
provided similar reports [11-13]. 
Intervention was done in 47% of the study 
population. Remaining people were recently 
diagnosed and without medication errors where 
intervention was not needed. In males, known case of 
asthma was found in 17 (39%) and newly diagnosed 
in 36 (61%). In females, known cases are found in 20 
(51%) and newly diagnosed in 16 (49%). 
Prescriber-related DRP was most commonly detected 
by conducting the structured medication review: 
 no drug prescribed but clear indication,  
 unnecessarily long duration of treatment,  
 dose of drug used being too low, and  
 Drug–drug interactions.  
 Side effects and lack of knowledge about the 
drugs were the most common DRP 
identified by patient interview.  
Prescription of drugs from hospital using five or 
more drugs for treatment of chronic asthma is associ-
ated with drug related problems. Previous study also 
proves the same [14]. As confirmed by the results of 
the present study, the number of medication errors 
increases with the number of drugs prescribed. 
Particularly in the patient group included in the 
present study, occurrence of drug related problems 
may result in increased risk of hospital readmission, 
morbidity, mortality, and health care costs [15,16].  
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CONCLUSION: 
This study shows that DRP occur frequently in 
patients using several drugs to treat chronic diseases. 
The number of DRP was also significantly associated 
with the number of drugs prescribed. Moreover, 
patients with polypharmacy had significantly more 
drug related problems. Patients discharged from the 
department of pulmonary diseases also had more 
DRP than those discharged from other departments.  
An important task for community pharmacists is to 
identify, resolve, and prevent the occurrence of drug 
related problems in this group of patients which, in 
the coming years, is expected to grow considerably in 
size. Using comprehensive tools to identify drug 
related problems, it is very important to develop 
intervention strategies to achieve this goal. 
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